Clinical trials: Blastocysts
Infertility
Prospective Observational Correlation of Sperm Assay Results With Blastocyst Formation
We will investigate potential correlation between SpermComet DNA fragmentation assay results and IVF cycle outcome.
- Trial name
- NCT02031549
- Testing
- SpermComet assay
- Where
- United States
- Volunteers
- 40 people, healthy volunteers welcome
- Sponsor
- Bruce Shapiro M.D.
Abnormal Karyotype
The Effectiveness of Blastocentesis Versus Trophectoderm Biopsy
For the purpose of this study, the investigators will perform the removal of trophectoderm (TE) the cells as required for the purpose of pre-implantation genetic screening, in order to perform the genetic analysis.
- Trial name
- NCT02915276
- Testing
- Blastocentisis, Trophectoderm biopsy
- Where
- United Kingdom
- Volunteers
- 250 people, healthy volunteers welcome
- Sponsor
- Center for Reproductive an Genetic Health
Controlled Ovarian Stimulation
Impact of Blastocyst Morphological Development and Blastocoele Re-expansion on Pregnancy Outcome After Using REKOVELLE®
The purpose of this observational study is to examine the development and appearance of embryos before and after freezing following a single controlled ovarian stimulation cycle using REKOVELLE® (follitropin delta) as the…
- Trial name
- NCT03697031
- Testing
- Follitropin Delta
- Where
- Denmark
- Volunteers
- 362 people
- Sponsor
- Ferring Pharmaceuticals
Fertility Disorders
Performance of CHLOE Algorithm on the Prediction of Blastocyst Formation
This is an observational, prospective, single-arm, multi-center, clinical study to evaluate the performance of CHLOE, an Artificial Intelligence (AI)-based software application, as adjunct information to support identifying…
- Trial name
- CHLOE (NCT05455281)
- Testing
- CHLOE
- Where
- 3 sites in United States, Israel
- Volunteers
- 55 people
- Sponsor
- Fairtility
Infertility
Study of Nolasiban to Increase Pregnancy Rates in Women Undergoing IVF
The primary objective of this study is to confirm the efficacy of a single oral 900 mg dose of nolasiban versus placebo to increase the ongoing clinical pregnancy rate at 10 weeks post-embryo transfer (ET) day.
- Trial name
- IMPLANT4 (NCT03758885)
- Testing
- Nolasiban
- Where
- 50 sites in Belgium, Canada and 8 more
- Volunteers
- 820 people
- Sponsor
- ObsEva SA
Infertility, Recurrent Pregnancy Loss
Preimplantation Genetic Diagnosis Using Blastocyst Biopsy and Array CGH
The investigators propose to perform a clinical randomized trial to evaluate the effect of single embryo (blastocyst) transfer (SET) with array CGH for the evaluation of the complete chromosome complement of the blastocyst in…
- Trial name
- NCT01546350
- Testing
- PGD
- Where
- 4 sites in United States
- Volunteers
- 200 people
- Sponsor
- Reprogenetics